ClariTrial | Search Clinical Trials

Explore/Depression

Status

Phase

47,126 results for “Depression”

Page 1 of 3142

Completed

Results posted

A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression

Phase 4Depression

duloxetinefluoxetinecitalopram+2 more

Eli Lilly and Company750 participants61 sites · United StatesCompletes Feb 2009

Compare CT.gov Full analysis →

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive Disorder

Phase 1Depressive Disorder, Major

JNJ-54175446, 600 mgJNJ-54175446, 150 mgPlacebo

Janssen Research & Development, LLC70 participants4 sites · Germany, NetherlandsCompletes Jun 2017

Compare CT.gov Full analysis →

Completed

Transforming Care and Payment Priorities for Vulnerable Families

N/ASocial Stress

Screening survey and accompanying handout for resources

Baylor College of Medicine430 participants1 site · United StatesCompletes Oct 2018

Compare CT.gov Full analysis →

Not Yet Recruiting

Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer

Phase 2Phase 3Hepatobiliary CancerPancreatic Cancer

Comprehensive Geriatric Assessment

Assistance Publique - Hôpitaux de Paris526 participants12 sites · FranceCompletes Apr 2030

Compare CT.gov Full analysis →

Completed

CIRcadian Rhythms and CortisoL. Effects on Substrate Metabolism and Clock Gene Expression and Functioning

N/AHealthy

PrednisolonePlacebo

University of Aarhus10 participants1 site · DenmarkCompletes Apr 2024

Compare CT.gov Full analysis →

Recruiting

The Effect of Combined Brain Stimulation and Yoga for Improving Cognitive Function in Psychosis

N/ACognitive FunctioningPsychosis

Active tDCSSham tDCSYoga

The Hong Kong Polytechnic University135 participants1 site · Hong KongCompletes Dec 2027

Compare CT.gov Full analysis →

Terminated

UK Registry for Baroreflex Activation Therapy

N/ABaroreflex Failure SyndromeHypertension, Resistant to Conventional Therapy

Baroreflex Activation Therapy with Barostim Neo

Queen Mary University of London6 participants1 site · United KingdomCompletes Nov 2021

Compare CT.gov Full analysis →

Completed

A Multicenter Clinical Study on Shuganjieyu Capsule Combined With Fluoxetine in the Treatment of Depression

N/AOutpatients / Inpatients With Depression

Shuganjieyu capsuleFluoxetinePlacebo

Peking University160 participants3 sites · ChinaCompletes May 2024

Compare CT.gov Full analysis →

Completed

Nitrous Oxide for Late-Life Depression - PROTO-BRAIN

N/ALate-Life DepressionResistant Depression, Treatment

EMONOMedical Air

University Hospital, Tours60 participants1 site · FranceCompletes Dec 2024

Compare CT.gov Full analysis →

Completed

Results posted

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

Phase 4Moderate to Severe Psoriasis

EtanerceptEtanercept + AcitretinAcitretin

Pfizer60 participants10 sites · South KoreaCompletes Apr 2011

Compare CT.gov Full analysis →

Completed

Results posted

Drug Use Investigation of Jzoloft.

N/APanic DisorderDepression

Sertraline hydrochloride

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2,272 participantsCompletes Sep 2011

Compare CT.gov Full analysis →

Completed

Behavioral Activation + Occupational Therapy

N/AMultiple Chronic ConditionsDisability Physical

Behavioral Activation + Occupational TherapyEnhanced Usual Care

University of Oklahoma41 participants1 site · United StatesCompletes Nov 2024

Compare CT.gov Full analysis →

Completed

Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and Lumpectomy

N/APersistent Postsurgical PainBreast Cancer FemaleDuctal Carcinoma in Situ

Acceptance and Commitment Therapy

Katherine Hadlandsmyth62 participants1 site · United StatesCompletes Nov 2017

Compare CT.gov Full analysis →

Withdrawn

Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid Hemorrhage

N/ASubarachnoid Hemorrhage

Esmolol

University of Michigan01 site · United StatesCompletes Jul 2015

Compare CT.gov Full analysis →

Completed

A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)

Phase 3Major Depressive Disorder (MDD)

LY03005 extended-release tabletPlacebo

Luye Pharma Group Ltd.558 participants1 site · ChinaCompletes Dec 2020

Compare CT.gov Full analysis →

1–15 of 47,126

Explore/Depression

Status

Phase

47,126 results for “Depression”

Page 1 of 3142

Completed

Results posted

A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression

Phase 4Depression

duloxetinefluoxetinecitalopram+2 more

Eli Lilly and Company750 participants61 sites · United StatesCompletes Feb 2009

Compare CT.gov Full analysis →

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive Disorder

Phase 1Depressive Disorder, Major

JNJ-54175446, 600 mgJNJ-54175446, 150 mgPlacebo

Janssen Research & Development, LLC70 participants4 sites · Germany, NetherlandsCompletes Jun 2017

Compare CT.gov Full analysis →

Completed

Transforming Care and Payment Priorities for Vulnerable Families

N/ASocial Stress

Screening survey and accompanying handout for resources

Baylor College of Medicine430 participants1 site · United StatesCompletes Oct 2018

Compare CT.gov Full analysis →

Not Yet Recruiting

Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer

Phase 2Phase 3Hepatobiliary CancerPancreatic Cancer

Comprehensive Geriatric Assessment

Assistance Publique - Hôpitaux de Paris526 participants12 sites · FranceCompletes Apr 2030

Compare CT.gov Full analysis →

Completed

CIRcadian Rhythms and CortisoL. Effects on Substrate Metabolism and Clock Gene Expression and Functioning

N/AHealthy

PrednisolonePlacebo

University of Aarhus10 participants1 site · DenmarkCompletes Apr 2024

Compare CT.gov Full analysis →

Recruiting

The Effect of Combined Brain Stimulation and Yoga for Improving Cognitive Function in Psychosis

N/ACognitive FunctioningPsychosis

Active tDCSSham tDCSYoga

The Hong Kong Polytechnic University135 participants1 site · Hong KongCompletes Dec 2027

Compare CT.gov Full analysis →

Terminated

UK Registry for Baroreflex Activation Therapy

N/ABaroreflex Failure SyndromeHypertension, Resistant to Conventional Therapy

Baroreflex Activation Therapy with Barostim Neo

Queen Mary University of London6 participants1 site · United KingdomCompletes Nov 2021

Compare CT.gov Full analysis →

Completed

A Multicenter Clinical Study on Shuganjieyu Capsule Combined With Fluoxetine in the Treatment of Depression

N/AOutpatients / Inpatients With Depression

Shuganjieyu capsuleFluoxetinePlacebo

Peking University160 participants3 sites · ChinaCompletes May 2024

Compare CT.gov Full analysis →

Completed

Nitrous Oxide for Late-Life Depression - PROTO-BRAIN

N/ALate-Life DepressionResistant Depression, Treatment

EMONOMedical Air

University Hospital, Tours60 participants1 site · FranceCompletes Dec 2024

Compare CT.gov Full analysis →

Completed

Results posted

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

Phase 4Moderate to Severe Psoriasis

EtanerceptEtanercept + AcitretinAcitretin

Pfizer60 participants10 sites · South KoreaCompletes Apr 2011

Compare CT.gov Full analysis →

Completed

Results posted

Drug Use Investigation of Jzoloft.

N/APanic DisorderDepression

Sertraline hydrochloride

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2,272 participantsCompletes Sep 2011

Compare CT.gov Full analysis →

Completed

Behavioral Activation + Occupational Therapy

N/AMultiple Chronic ConditionsDisability Physical

Behavioral Activation + Occupational TherapyEnhanced Usual Care

University of Oklahoma41 participants1 site · United StatesCompletes Nov 2024

Compare CT.gov Full analysis →

Completed

Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and Lumpectomy

N/APersistent Postsurgical PainBreast Cancer FemaleDuctal Carcinoma in Situ

Acceptance and Commitment Therapy

Katherine Hadlandsmyth62 participants1 site · United StatesCompletes Nov 2017

Compare CT.gov Full analysis →

Withdrawn

Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid Hemorrhage

N/ASubarachnoid Hemorrhage

Esmolol

University of Michigan01 site · United StatesCompletes Jul 2015

Compare CT.gov Full analysis →

Completed

A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)

Phase 3Major Depressive Disorder (MDD)

LY03005 extended-release tabletPlacebo

Luye Pharma Group Ltd.558 participants1 site · ChinaCompletes Dec 2020

Compare CT.gov Full analysis →

1–15 of 47,126